Vimarsana
Biggest News Aggregation in the World

Page 3 - Dexcel Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dexcel Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dexcel Pharma Today - Breaking & Trending Today

New Drug Filing for Cenobamate Accepted for Review in Canada and Israel - Vimarsana News

New Drug Filing for Cenobamate Accepted for Review in Canada and Israel

SK Biopharmaceuticals is eligible to receive milestones for future approval and commercialization in Canada and IsraelPANGYO, South Korea, Aug. 9,...

Innocan Pharma Corporation: Former Dexcel Pharma Analytical Chemist to Join Innocan Pharma LPT Pharmaceutical R&D Team as it is Moving Forward with the LPT Development - Vimarsana News

Innocan Pharma Corporation: Former Dexcel Pharma Analytical Chemist to Join Innocan Pharma LPT Pharmaceutical R&D Team as it is Moving Forward with the LPT Development

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 12, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it

Kriya Therapeutics Raises $270M in Series C Financing - Vimarsana News

Kriya Therapeutics Raises $270M in Series C Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Durham's Kriya Adds $270M to Coffers, Bringing Total Raised to Date to $450.5M for Gene Therapies - Vimarsana News

Durham's Kriya Adds $270M to Coffers, Bringing Total Raised to Date to $450.5M for Gene Therapies

Durham's Kriya Therapeutics just added $270 million to its coffers, bringing its total raised to date to roughly $450 million for novel gene therapies

Pfizer (NYSE:PFE) and Lannett (NYSE:LCI) Critical Survey - Vimarsana News

Pfizer (NYSE:PFE) and Lannett (NYSE:LCI) Critical Survey

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.